Artificial Intelligence for In Silico Clinical Trials: A Review

09/16/2022
by   Zifeng Wang, et al.
35

A clinical trial is an essential step in drug development, which is often costly and time-consuming. In silico trials are clinical trials conducted digitally through simulation and modeling as an alternative to traditional clinical trials. AI-enabled in silico trials can increase the case group size by creating virtual cohorts as controls. In addition, it also enables automation and optimization of trial design and predicts the trial success rate. This article systematically reviews papers under three main topics: clinical simulation, individualized predictive modeling, and computer-aided trial design. We focus on how machine learning (ML) may be applied in these applications. In particular, we present the machine learning problem formulation and available data sources for each task. We end with discussing the challenges and opportunities of AI for in silico trials in real-world applications.

READ FULL TEXT
research
04/07/2023

SPOT: Sequential Predictive Modeling of Clinical Trial Outcome with Meta-Learning

Clinical trials are essential to drug development but time-consuming, co...
research
12/15/2021

TrialGraph: Machine Intelligence Enabled Insight from Graph Modelling of Clinical Trials

A major impediment to successful drug development is the complexity, cos...
research
06/06/2023

PyTrial: A Comprehensive Platform for Artificial Intelligence for Drug Development

Drug development is a complex process that aims to test the efficacy and...
research
12/15/2017

Anscombe's Model for Sequential Clinical Trials Revisited

In Anscombe's classical model, the objective is to find the optimal sequ...
research
12/25/2022

Modeling restricted enrollment and optimal cost-efficient design in multicenter clinical trials

Design and forecasting of patient enrollment is among the greatest chall...
research
12/22/2021

Conditional Drug Approval with the Harmonic Mean Chi-Squared Test

Approval of treatments in areas of high medical need may not follow the ...
research
10/12/2022

Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints

Non-alcoholic steatohepatitis (NASH), an inflammatory and more progressi...

Please sign up or login with your details

Forgot password? Click here to reset